These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3322310)

  • 1. Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial.
    World MJ; Ryle PR; Aps EJ; Shaw GK; Thomson AD
    Alcohol Alcohol; 1987; 22(4):331-40. PubMed ID: 3322310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
    World MJ; Aps EJ; Shaw GK; Thomson AD
    Alcohol Alcohol; 1984; 19(1):23-9. PubMed ID: 6149758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
    Bel A; Chambon A
    Minerva Dietol Gastroenterol; 1977; 23(3):243-8. PubMed ID: 372846
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
    Trinchet JC; Beaugrand M; Callard P; Hartmann DJ; Gotheil C; Nusgens BV; Lapiere CM; Ferrier JP
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):551-5. PubMed ID: 2753302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of alcoholic liver disease with propylthiouracil.
    Orrego H; Blake JE; Blendis LM; Compton KV; Israel Y
    N Engl J Med; 1987 Dec; 317(23):1421-7. PubMed ID: 3317042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams.
    Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1757-64. PubMed ID: 14634491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 9. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis.
    Gluud C; Christoffersen P; Eriksen J; Wantzin P; Knudsen BB
    Am J Gastroenterol; 1987 Jul; 82(7):660-4. PubMed ID: 3300274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases.
    Hepatology; 1986; 6(5):807-13. PubMed ID: 2875927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W; Boyer T; Omata M; Redeker A; Reynolds T
    Gastroenterology; 1980 Mar; 78(3):524-9. PubMed ID: 6985881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen use in patients who drink alcohol: current study evidence.
    Kuffner EK; Dart RC
    Am J Manag Care; 2001 Dec; 7(19 Suppl):S592-6. PubMed ID: 11776481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
    Wells JT; Said A; Agni R; Tome S; Hughes S; Dureja P; Lucey MR
    Liver Transpl; 2007 Dec; 13(12):1728-35. PubMed ID: 18044757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.